% | $
Quotes you view appear here for quick access.

CEL-SCI Corporation Message Board

  • cmegladon cmegladon Nov 19, 2009 12:09 PM Flag

    The Resurrection

    1986 Cel Sci announces lab study using Cel-1000 shows great results in mice. Never proceeds.
    Several great animal studies confirming potential treatment of other diseases and viruses.
    Studies do not proceed.
    The bottom dropped out of Biotech, but though perserverance, somehow Cel Sci stayed afloat.
    Now, CEL-1000 Cel-Sci Preclinical filed with the FDA, LEAPs IND, MK P III for Head and Neck and potentially for Cancer of the Cervix, several studies will commence (IMO), more than we know about.
    What do you think will happen when Zenilman see the cell action when the WBCs are treated with LEAPs?
    Don't bet against him thinking what else this novel treatment will be used for.
    He is the Chief of the Department of Infectious Diseases at Johns Hopkins.
    And, we're sitting with 40 Million in the bank to co-fund studies and trials.
    Then we have the cold fill facility.
    I never really gave this much in the way of a revenue producer, but after reading up, I see there is a need not only for a facility to produce vaccines, but many small Biotechs outsource all there manufacturing to other facilities for use of Bioreactors. Also, stem cell work will be on the rise, significantly so, and I'm thinking their facility will be available for that as well.
    This is an investment.
    IF we see drops now and then, if you can, add to your position. And believe it or not, as benchmarks are met and the price rises, will add again.
    No time frames. I repeat NO TIME FRAME.
    Just wait. Be patient, and I really believe we will be rewarded beyond our hopes.

    SortNewest  |  Oldest  |  Most Replied Expand all replies
0.471-0.019(-3.86%)Aug 25 4:02 PMEDT